26 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, regulators, self-regulatory organizations and other stakeholders have expressed an interest in Environmental, Social and Corporate Governance (“ESG”) matters … result in substantial civil and criminal penalties and suspension or debarment from government contracting.
If we fail to comply with environmental
D
AUTL
Autolus Therapeutics plc
23 Feb 24
Exempt offering of security
5:28pm
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health
8-K
EX-1.1
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
, “Environmental Laws”), (B) the Company and its subsidiaries have all Permits required under any applicable Environmental Laws and are each in compliance … , liens, notices of noncompliance or violation, investigations or proceedings relating to any Environmental Law against the Company or any of its
8-K
EX-10.1
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
supplier, manufacturer, customer or contractor of the Company, exists or, to the Company’s Knowledge, is threatened or imminent.
4.15. Environmental … , “Environmental Laws”), (B) the Company and its subsidiaries have all permits required under any applicable Environmental Laws and are each in compliance
10-Q
2023 Q3
EX-10.1
AUTL
Autolus Therapeutics plc
9 Nov 23
Quarterly report
4:18pm
; (c) block up or obstruct any outside doors or windows; (d) stop off or affect the working of any Service Media; (e) adversely affect the environmental
6-K
EX-1.1
5kdw8v32nrmrkhhh k7s
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K
EX-1
siazpu6pk58tg
1 Jul 22
Current report (foreign)
5:15pm
6-K
EX-99.1
hyclactt
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-1
x8ju 42wz8nb
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-1.1
n4j4aqx 46op
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-1.1
w4z03d
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
6-K
EX-1
dnf7oon7bp6ol70a
26 May 20
Current report (foreign)
4:31pm
6-K
EX-1.1
tpgjthgo
24 Jan 20
Autolus Announces Proposed Public Offering in the United States
4:06pm
F-1
EX-1.1
mx9gyyo
8 Apr 19
Registration statement (foreign)
4:34pm
6-K
EX-1
ibj26sotpbv4np p5
15 Mar 19
Annual Report and Accounts
5:26pm
20-F
5v1e0bv
23 Nov 18
Annual report (foreign)
12:00am